| abstract |
Monoclonal and polyclonal antibodies and fragments thereof are described which are capable of binding to specific members or groups of 0,0-dialkyl-0-(X) phosphorothioate compounds, where X is an aromatic or heterocyclic group or substituted aromatic or substituted heterocyclic group. Hybridoma cell lines, methods for making the antibodies, and assays and kits including the antibodies are also disclosed. |